Hannah Schrutz

Papers

Total Citations

H-Index

About

Hannah Schrutz is a leading urological surgeon and clinical researcher whose work centers on advancing minimally invasive surgical techniques for kidney cancer. Her primary research areas include robotic-assisted partial nephrectomy, comparative surgical approaches, and peri-operative outcomes in oncology. Schrutz is best known for her pivotal role in the ROPARN study, a randomised controlled feasibility trial that rigorously compared retroperitoneal versus transperitoneal robot-assisted partial nephrectomy. This landmark work, published in 2025 and already cited 9 times, demonstrated that the retroperitoneal approach offers significant time advantages and reduced peri-operative morbidity while maintaining equivalent oncological efficacy to the traditional transperitoneal method. By providing high-quality evidence for surgical decision-making, Schrutz has directly influenced clinical protocols and helped refine best practices for nephron-sparing surgery. Her research bridges the gap between technical innovation and patient-centered outcomes, offering surgeons a clearer roadmap for optimizing recovery without compromising cancer control. With her methodical approach to trial design and commitment to evidence-based surgery, Schrutz is shaping the future of robotic urology and improving the standard of care for kidney cancer patients worldwide.